Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference

SOUTH SAN FRANCISCO, Calif., June 12 Exelixis,Inc. (Nasdaq: EXEL) announced today that Frank Karbe, executive vice presidentand chief financial officer of Exelixis, will present at the William Blair &Company 28th Annual Growth Stock Conference at 1:10 p.m. PT/4:10 p.m. ET onThursday, June 19, 2008. Mr. Karbe will discuss updates to the company'sdevelopment pipeline and corporate strategy.

The presentation will be webcast and may be accessed in the Event Calendarpage under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated tothe discovery and development of novel small molecule therapeutics for thetreatment of cancer and other serious diseases. The company is leveraging itsfully integrated drug discovery platform to fuel the growth of its developmentpipeline, which is primarily focused on cancer. Currently, Exelixis' broadproduct pipeline includes investigational compounds in phase 2 and phase 1clinical development. Exelixis has established strategic corporate allianceswith major pharmaceutical and biotechnology companies, includingGlaxoSmithKline, Bristol-Myers Squibb, Genentech, Wyeth Pharmaceuticals, andDaiichi-Sankyo. For more information, please visit the company's website athttp://www.exelixis.com.

SOURCE Exelixis, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...